Three Phase III Randomized Controlled Trials of Topical Resiquimod 0.01-Percent Gel to Reduce Anogenital Herpes Recurrences

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00077-14

Related search